Evaluation of optimal infusion volume with liposomal amphotericin B (L-AMB) administration for chronic pulmonary aspergillosis
Not Applicable
Recruiting
- Conditions
- Chronic pulmonary aspergillosis
- Registration Number
- JPRN-UMIN000012687
- Lead Sponsor
- Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who received L-AMB within one month before the time of enrollment 2.Patients with intravenous leukocyte infusion 3.Pregnant patients 4.Patients with renal insufficiency(CKD morethan 3b) 5.Patients anticipating being postrenal failure using abdominal ultracound 6.Patients with cardiac disorders(EF less than 50% or E/A more than 1 using echocardiography) 7.Patients deemed ineligible by the attending physicians for various reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the renal dysfunction between hydration group and non-hydration group
- Secondary Outcome Measures
Name Time Method The change of various electrolytes The change of renal dysfunctional marker The change of body weight